Rationale: Primary pancreatic tuberculosis is extremely rare, it presents with non-specific clinical symptoms and imaging features; it may be falsely identified as a malignancy of the pancreas.
Introduction
Tuberculosis is a worldwide infectious disease caused by Mycobacterium tuberculosis, which most often affects the lungs. Abdominal tuberculosis can usually occur in developing and endemic countries; it can affect the peritoneum, gastrointestinal tract, lymph nodes, and the spleen. [1] However, primary pancreatic tuberculosis is rare in non-immunocompromised patients, which accounts for less than 5% of all tuberculosis cases, [2] and particularly extremely rare with elevated serum CA 19-9 levels. It is frequently misdiagnosed as pancreatic malignancy, therefore a multitude of cases confirm the diagnosis only after histopathological examination of the specimens obtained after performing unnecessary surgery. A correct preoperative diagnosis of pancreatic tuberculosis is very important, which can avoid unnecessary surgeries. We present a case of isolated primary pancreatic tuberculosis with elevated CA 19-9 level and obstructive jaundice that was initially diagnosed as a malignancy.
Case presentation
A 41-year-old male with no history of tuberculosis presented to our hospital with a two-week history of jaundice without abdominal pain, fever, a cough and night sweats. He or his family had no history of tuberculosis and he was not taking any medical treatment. Physical examination revealed marked jaundice and tenderness over the right upper abdomen. There were no enlarged superficial lymph nodes nor were any palpable mass in the abdomen; the liver and spleen were not enlarged. Abdominal computed tomography (CT) showed a 40 Â 45 mm heterogeneous irregular hypodense mass in the head of the pancreas causing dilatation of the common bile duct (CBD), and it was enhanced after infusion of contrast material. There was no pancreatic duct dilatation. Enlarged portocaval and peripancreatic lymph nodes were also detected. chest CT scan found no abnormalities (Fig. 1) .
Magnetic resonance imaging (MRI) revealed an irregular heterogeneous mass of 38 Â 42 mm in the head of the pancreas. The lesion showed slightly decreased signal intensity on T1-weighted images and slightly increased signal intensity on T2-weighted images. A dilated intrahepatic and extrahepatic duct was found on magnetic resonance cholangiopancreatography (Fig. 2) .
According to the clinical setting, laboratory findings, and radiological features, the diagnosis of pancreatic carcinoma was considered and a laparotomy was performed.
Quickly frozen pathological examination of the lymph nodes showed chronic inflammation. However, the diagnosis still could not be confirmed by fine needle aspiration (FNA) from the pancreatic mass. Hence, we subsequently decided to be performed pancreatoduodenectomy.
The pathological photomicrograph showed epithelioid cells and multinucleated giant cells. These confirmed the diagnosis of pancreatic tuberculosis (Fig. 3) . Acid-fast stain of the drainage confirmed the presence of Mycobacterium. Then Isoniazid, rifampicin, and ethambutol were given for 6 months. No evidence of recurrence was noted, and the patient remained free of symptoms during the follow-up examination 1 year after surgery.
Discussion
Isolated pancreatic tuberculosis is extremely rare, even in countries where tuberculosis is endemic. [3] The explanation for this low prevalence may be that pancreatic enzymes can destroy mycobacteria. [4, 5] Pancreatic tuberculosis is mainly caused via the lymphatic system or hematogenous spread. [6] However, in our case, tuberculosis in the lungs or other organs were not found, We do not know how this case is infected. There are no typical clinical symptoms for pancreatic tuberculosis, it presents with a wide spectrum of symptoms such as non-specific abdominal pain, fever, night sweats, weight loss, acute or chronic pancreatitis, portal vein compression, gastrointestinal bleeding, and obstructive jaundice mimicking pancreatic malignancy. [7] [8] [9] [10] However, this case only showed signs of obstructive jaundice without pain. There are no pathognomonic radiologic features for pancreatic TB. CT may show enhanced hypodense lesions with irregular borders; lesions usually are cystic and multiloculate. Peripancreatic and periportal lymphadenopathy with peripheral ring enhancement may be found. [11] MRI findings of isolated pancreatic TB include a sharply delineated mass, exhibiting heterogeneous enhancement often located in the pancreatic head. These lesions are characteristically hypointense on fat-suppressed T1-weighted imaging and show a mixture of hypo-or hyperintensity on T2-weighted imaging. [12] If there are no specific signs and symptoms of tuberculosis, radiologically pancreatic tuberculosis is easily misdiagnosed as a solid pseudopapillary tumor, lymphoma, or pancreatic carcinoma. Especially when with an elevated serum CA 19-9 level, it is easily misdiagnosed as pancreatic carcinoma such as seen in this case. [13] Biliary obstruction caused by a mass in the pancreas can lead to temporary elevated serum CA 19-9 levels. Therefore, even with elevated serum CA 19-9 levels, pancreatic tuberculosis cannot be excluded when the mass is located on the head of the pancreas. The diagnosis of pancreatic tuberculosis is usually difficult before the operation and is often confirmed by intraoperative pathological examination. In recent years, endoscopic ultrasound-guided fine needle aspiration cytodiagnosis (FNAC) was proven to be an excellent tool for the cytological diagnosis of pancreatic tuberculosis, which can help avoid unnecessary surgery. [14] [15] [16] If tuberculosis cannot be confirmed by preoperative FNAC, tissue biopsy can be performed, guided by laparoscopy. Once pancreatic tuberculosis is diagnosed, unnecessary pancreatoduodenectomy or pancreatic resection should be avoided because of postoperative pancreatic fistulas, which can cause abdominal infection, bleeding, and even death. The majority of pancreatic tuberculosis cases respond well to standard anti-tubercular therapy with isoniazid, rifampin, pyrazinamide, and ethambutol or streptomycin for 6 to 12 months. [17] 
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